| Year |
Citation |
Score |
| 2023 |
Rayala R, Tiller A, Majumder SA, Stacy HM, Eans SO, Nedovic A, McLaughlin JP, Cudic P. Solid-Phase Synthesis of the Bicyclic Peptide OL-CTOP Containing Two Disulfide Bridges, and an Assessment of Its In Vivo μ-Opioid Receptor Antagonism after Nasal Administration. Molecules (Basel, Switzerland). 28. PMID 36838810 DOI: 10.3390/molecules28041822 |
0.572 |
|
| 2021 |
Gil J, Pastar I, Houghten RA, Padhee S, Higa A, Solis M, Valdez J, Head CR, Michaels H, Lenhart B, Simms C, Williams B, Cudic P, Davis SC. Novel Cyclic Lipopeptides Fusaricidin Analogs for Treating Wound Infections. Frontiers in Microbiology. 12: 708904. PMID 34367114 DOI: 10.3389/fmicb.2021.708904 |
0.545 |
|
| 2019 |
Sajja RK, Cudic P, Cucullo L. In vitro characterization of odorranalectin for peptide-based drug delivery across the blood-brain barrier. Bmc Neuroscience. 20: 22. PMID 31068126 DOI: 10.1186/S12868-019-0504-X |
0.371 |
|
| 2017 |
Rodriguez MC, Yongye AB, Cudic M, Martinez Mayorga K, Liu E, Mueller BM, Ainsley J, Karabencheva-Christova T, Christov CZ, Cudic M, Cudic P. Targeting cancer-specific glycans by cyclic peptide lectinomimics. Amino Acids. PMID 28894966 DOI: 10.1007/S00726-017-2485-3 |
0.635 |
|
| 2017 |
Min KR, Galvis A, Williams B, Rayala R, Cudic P, Ajdic D. Antibacterial and Antibiofilm Activities of a Novel Synthetic Cyclic Lipopeptide Against Cariogenic Streptococcus mutans UA159. Antimicrobial Agents and Chemotherapy. PMID 28533236 DOI: 10.1128/Aac.00776-17 |
0.759 |
|
| 2017 |
Rodriguez MC, Bionda N, Johnson CA, Jakas A, Čudić P. Bicyclic Peptide Based Lectinomimic Croatica Chemica Acta. 90. DOI: 10.5562/Cca3295 |
0.656 |
|
| 2016 |
Jakas A, Perc M, Suć J, Rodriguez MC, Cudic M, Cudic P. Synthesis of anthrose lipidic derivative as mimic of B. anthracis BclA glycoprotein for use in ELISA-like binding assays Journal of Carbohydrate Chemistry. 1-17. DOI: 10.1080/07328303.2016.1139124 |
0.5 |
|
| 2015 |
Cudic P, Joshi N, Sagher D, Williams BT, Stawikowski MJ, Weissbach H. Identification of activators of methionine sulfoxide reductases A and B. Biochemical and Biophysical Research Communications. PMID 26718410 DOI: 10.1016/J.Bbrc.2015.12.077 |
0.41 |
|
| 2015 |
Bionda N, Fleeman RM, de la Fuente-Núñez C, Rodriguez MC, Reffuveille F, Shaw LN, Pastar I, Davis SC, Hancock RE, Cudic P. Identification of novel cyclic lipopeptides from a positional scanning combinatorial library with enhanced antibacterial and antibiofilm activities. European Journal of Medicinal Chemistry. 108: 354-363. PMID 26703794 DOI: 10.1016/J.Ejmech.2015.11.032 |
0.793 |
|
| 2014 |
Otvos L, Knappe D, Hoffmann R, Kovalszky I, Olah J, Hewitson TD, Stawikowska R, Stawikowski M, Cudic P, Lin F, Wade JD, Surmacz E, Lovas S. Development of second generation peptides modulating cellular adiponectin receptor responses. Frontiers in Chemistry. 2: 93. PMID 25368867 DOI: 10.3389/Fchem.2014.00093 |
0.329 |
|
| 2014 |
Otvos L, Vetter SW, Koladia M, Knappe D, Schmidt R, Ostorhazi E, Kovalszky I, Bionda N, Cudic P, Surmacz E, Wade JD, Hoffmann R. The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor. Amino Acids. 46: 873-82. PMID 24366600 DOI: 10.1007/S00726-013-1650-6 |
0.739 |
|
| 2014 |
Bionda N, Pastar I, Davis SC, Cudic P. In vitro and in vivo activities of novel cyclic lipopeptides against staphylococcal biofilms. Protein and Peptide Letters. 21: 352-6. PMID 24164269 DOI: 10.2174/09298665113206660101 |
0.753 |
|
| 2013 |
Li Y, Bionda N, Yongye A, Geer P, Stawikowski M, Cudic P, Martinez K, Houghten RA. Dissociation of antimicrobial and hemolytic activities of gramicidin S through N-methylation modification. Chemmedchem. 8: 1865-72. PMID 24023000 DOI: 10.1002/Cmdc.201300232 |
0.714 |
|
| 2013 |
Bionda N, Cudic P. Solid-phase guanidinylation of peptidyl amines compatible with standard Fmoc-chemistry: formation of monosubstituted guanidines. Methods in Molecular Biology (Clifton, N.J.). 1081: 151-65. PMID 24014439 DOI: 10.1007/978-1-62703-652-8_10 |
0.732 |
|
| 2013 |
Pitteloud JP, Bionda N, Cudic P. Synthesis of side chain N,N'-diaminoalkylated derivatives of basic amino acids for application in solid-phase peptide synthesis. Methods in Molecular Biology (Clifton, N.J.). 1081: 61-75. PMID 24014434 DOI: 10.1007/978-1-62703-652-8_5 |
0.744 |
|
| 2013 |
Bionda N, Pitteloud JP, Cudic P. Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria. Future Medicinal Chemistry. 5: 1311-30. PMID 23859209 DOI: 10.4155/Fmc.13.86 |
0.737 |
|
| 2013 |
Bionda N, Fleeman RM, Shaw LN, Cudic P. Effect of ester to amide or N-methylamide substitution on bacterial membrane depolarization and antibacterial activity of novel cyclic lipopeptides. Chemmedchem. 8: 1394-402. PMID 23780744 DOI: 10.1002/Cmdc.201300173 |
0.75 |
|
| 2013 |
Bionda N, Pitteloud JP, Cudic P. Solid-phase synthesis of fusaricidin/LI-F class of cyclic lipopeptides: Guanidinylation of resin-bound peptidyl amines. Biopolymers. 100: 160-6. PMID 23436339 DOI: 10.1002/bip.22186 |
0.738 |
|
| 2013 |
Pitteloud JP, Bionda N, Cudic P. Direct access to side chain N,N'-diaminoalkylated derivatives of basic amino acids suitable for solid-phase peptide synthesis. Amino Acids. 44: 321-33. PMID 22714010 DOI: 10.1007/s00726-012-1336-5 |
0.723 |
|
| 2012 |
Bionda N, Stawikowski M, Stawikowska R, Cudic M, López-Vallejo F, Treitl D, Medina-Franco J, Cudic P. Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity. Chemmedchem. 7: 871-82. PMID 22392790 DOI: 10.1002/cmdc.201200016 |
0.737 |
|
| 2012 |
Bionda N, Cudic M, Barisic L, Stawikowski M, Stawikowska R, Binetti D, Cudic P. A practical synthesis of N α-Fmoc protected L-threo-β-hydroxyaspartic acid derivatives for coupling via α- or β-carboxylic group. Amino Acids. 42: 285-93. PMID 21082204 DOI: 10.1007/S00726-010-0806-X |
0.722 |
|
| 2011 |
Bionda N, Cudic P. Cyclic lipodepsipeptides in novel antimicrobial drug discovery Croatica Chemica Acta. 84: 315-329. DOI: 10.5562/Cca1819 |
0.727 |
|
| 2009 |
James-Johnson C, Cudic P. Bicyclic organo-peptides as models for carbohydrate binding proteins. Advances in Experimental Medicine and Biology. 611: 593-4. PMID 19400325 DOI: 10.1007/978-0-387-73657-0_258 |
0.67 |
|
| 2009 |
Stawikowska R, Stawikowski M, Cudic P. Progress toward total solid-phase synthesis of depsipeptide antibiotic katanosin B. Advances in Experimental Medicine and Biology. 611: 385-6. PMID 19400235 DOI: 10.1007/978-0-387-73657-0_168 |
0.303 |
|
| 2009 |
Otvos L, Cassone M, Inacio VO, Noto P, Rux JJ, Wade JD, Cudic P. Synergy between a lead proline-rich antibacterial peptide derivative and small molecule antibiotics. Advances in Experimental Medicine and Biology. 611: 375-8. PMID 19400232 DOI: 10.1007/978-0-387-73657-0_165 |
0.454 |
|
| 2008 |
Cudic P, Stawikowski M. Peptidomimetics: Fmoc solid-phase pseudopeptide synthesis. Methods in Molecular Biology (Clifton, N.J.). 494: 223-46. PMID 18726577 DOI: 10.1007/978-1-59745-419-3_13 |
0.447 |
|
| 2008 |
Cassone M, Vogiatzi P, La Montagna R, De Olivier Inacio V, Cudic P, Wade JD, Otvos L. Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics. Peptides. 29: 1878-86. PMID 18721837 DOI: 10.1016/J.Peptides.2008.07.016 |
0.425 |
|
| 2008 |
Otvos L, Terrasi M, Cascio S, Cassone M, Abbadessa G, De Pascali F, Scolaro L, Knappe D, Stawikowski M, Cudic P, Wade JD, Hoffmann R, Surmacz E. Development of a pharmacologically improved peptide agonist of the leptin receptor. Biochimica Et Biophysica Acta. 1783: 1745-54. PMID 18555805 DOI: 10.1016/J.Bbamcr.2008.05.007 |
0.414 |
|
| 2007 |
Stawikowski M, Cudic P. Depsipeptide synthesis. Methods in Molecular Biology (Clifton, N.J.). 386: 321-39. PMID 18604953 DOI: 10.1007/978-1-59745-430-8_13 |
0.344 |
|
| 2007 |
Cudic P, Stawikowski M. Pseudopeptide synthesis via Fmoc solid-phase synthetic methodology Mini-Reviews in Organic Chemistry. 4: 268-280. DOI: 10.2174/157019307782411716 |
0.438 |
|
| 2006 |
Stawikowski M, Cudic P. A novel strategy for the solid-phase synthesis of cyclic lipodepsipeptides. Tetrahedron Letters. 47: 8587-8590. PMID 17440603 DOI: 10.1016/J.Tetlet.2006.09.116 |
0.432 |
|
| 2006 |
Otvos L, de Olivier Inacio V, Wade JD, Cudic P. Prior antibacterial peptide-mediated inhibition of protein folding in bacteria mutes resistance enzymes. Antimicrobial Agents and Chemotherapy. 50: 3146-9. PMID 16940114 DOI: 10.1128/Aac.00205-06 |
0.457 |
|
| 2004 |
Piantanida I, Palm BS, Čudić P, Žinić M, Schneider H. Interactions of acyclic and cyclic bis-phenanthridinium derivatives with ss- and ds-polynucleotides Tetrahedron. 60: 6225-6231. DOI: 10.1016/J.Tet.2004.05.009 |
0.615 |
|
| 2002 |
McCafferty DG, Cudic P, Frankel BA, Barkallah S, Kruger RG, Li W. Chemistry and biology of the ramoplanin family of peptide antibiotics. Biopolymers. 66: 261-84. PMID 12491539 DOI: 10.1002/Bip.10296 |
0.71 |
|
| 2002 |
Cudic P, Behenna DC, Kranz JK, Kruger RG, Wand AJ, Veklich YI, Weisel JW, McCafferty DG. Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin. Chemistry & Biology. 9: 897-906. PMID 12204689 DOI: 10.1016/S1074-5521(02)00191-6 |
0.718 |
|
| 2002 |
Cudic P, Kranz JK, Behenna DC, Kruger RG, Tadesse H, Wand AJ, Veklich YI, Weisel JW, McCafferty DG. Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation. Proceedings of the National Academy of Sciences of the United States of America. 99: 7384-9. PMID 12032292 DOI: 10.1073/Pnas.102192099 |
0.686 |
|
| 2001 |
Cudic P, Behenna DC, Yu MK, Kruger RG, Szewczuk LM, McCafferty DG. Synthesis of P(1)-Citronellyl-P(2)-alpha-D-pyranosyl pyrophosphates as potential substrates for the E. coli undecaprenyl-pyrophosphoryl-N-acetylglucoseaminyl transferase MurG. Bioorganic & Medicinal Chemistry Letters. 11: 3107-10. PMID 11720853 DOI: 10.1016/S0960-894X(01)00653-9 |
0.604 |
|
| 2001 |
Piantanida I, Palm BS, Cudic P, Zinic M, Schneider HJ. Phenanthridinium cyclobisintercalands. Fluorescence sensing of AMP and selective binding to single-stranded nucleic acids Tetrahedron Letters. 42: 6779-6783. DOI: 10.1016/S0040-4039(01)01386-7 |
0.595 |
|
| 1999 |
McCafferty DG, Cudic P, Yu MK, Behenna DC, Kruger R. Synergy and duality in peptide antibiotic mechanisms. Current Opinion in Chemical Biology. 3: 672-80. PMID 10600730 DOI: 10.1016/S1367-5931(99)00025-3 |
0.71 |
|
| 1999 |
Cudic P, Vigneron J, Lehn J, Cesario M, Prangé T. Molecular Recognition of Azobenzene Dicarboxylates by Acridine-Based Receptor Molecules; Crystal Structure of the Supramolecular Inclusion Complex of trans-3,3′-Azobenzene Dicarboxylate with a Cyclo-bis-intercaland Receptor European Journal of Organic Chemistry. 1999: 2479-2484. DOI: 10.1002/(Sici)1099-0690(199910)1999:10<2479::Aid-Ejoc2479>3.0.Co;2-N |
0.392 |
|
| 1995 |
Čudić P, Žinić M, Tomišić V, Simeon V, Vigneron J, Lehn J. Binding of nucleotides in water by phenanthridinium bis(intercaland) receptor molecules Journal of the Chemical Society, Chemical Communications. 1073-1075. DOI: 10.1039/C39950001073 |
0.652 |
|
| 1992 |
Žinić M, Čudić P, Škarić V, Vigneron J, Lehn J. Cyclo-bis-intercaland receptors with phenanthridine subunits Tetrahedron Letters. 33: 7417-7420. DOI: 10.1016/S0040-4039(00)60204-6 |
0.638 |
|
| 1991 |
Čudić P, Klaić B, Raza Z, Šepac D, Šunjić V. Synthesis and properties of some Rh(I) catalytic complexes with dinitrogen ligands derived from 5-Pyrido-1,4-benzodiazepin-4-ones Tetrahedron. 47: 5295-5308. DOI: 10.1016/S0040-4020(01)87141-6 |
0.303 |
|
| Show low-probability matches. |
